While homozygous for CCR5 deletion has Δ32-protection against HIV [43,44,45], heterozygous for the mutation has a delay of two to four years of progression to acquired immune deficiency syndrome (AIDS) [46,47,48]. This evidence concerns the gene CCR5 and AIDS.